Gain Therapeutics Inc (GANX)
2.43
-0.07
(-2.80%)
USD |
NASDAQ |
May 22, 16:00
2.43
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Shareholders Equity (Quarterly): 8.642M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.642M |
| December 31, 2023 | 12.58M |
| September 30, 2023 | 7.331M |
| June 30, 2023 | 11.09M |
| March 31, 2023 | 15.14M |
| December 31, 2022 | 18.88M |
| September 30, 2022 | 22.66M |
| Date | Value |
|---|---|
| June 30, 2022 | 27.02M |
| March 31, 2022 | 31.83M |
| December 31, 2021 | 34.82M |
| September 30, 2021 | 37.55M |
| June 30, 2021 | 41.39M |
| March 31, 2021 | 44.46M |
| December 31, 2020 | 6.202M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.202M
Minimum
Dec 2020
44.46M
Maximum
Mar 2021
22.83M
Average
20.77M
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 12.81B |
| Alpine Immune Sciences Inc | 332.70M |
| Outlook Therapeutics Inc | -134.24M |
| OptiNose Inc | -99.22M |
| Greenwich LifeSciences Inc | 5.121M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.58M |
| Total Liabilities (Quarterly) | 5.935M |